Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases

This publication has 60 references indexed in Scilit:

• Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-κB
  Biochemical and Biophysical Research Communications, 2003
• Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cells
  The Prostate, 2003
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• A Major Constituent of Green Tea, EGCG, Inhibits the Growth of a Human Cervical Cancer Cell Line, CaSki Cells, through Apoptosis, G₁ Arrest, and Regulation of Gene Expression
  DNA and Cell Biology, 2003
• ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
  The FASEB Journal, 2002
• Natural antimutagenic agents may prolong efficacy of human immunodeficiency virus drug therapy
  Medical Hypotheses, 1997
• Highlights of the Cancer Chemoprevention Studies in China
  Preventive Medicine, 1993
• Inhibitory effect of green tea on tumorigenesis by chemicals and ultraviolet light
  Preventive Medicine, 1992
• (—)‐Epigallocatechin‐3‐gallate incamellia sinensisleaves from Himalayan region of Sikkim: Inhibitory effects against biochemical events and tumor initiation in sencar mouse skin
  Nutrition and Cancer, 1992
• Crude tea extracts decrease the mutagenic activity of N-methyl-N′-nitro-N-nitrosoguanidine in vitro and in intragastric tract of rats
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989